Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03982602 · ClinicalTrials.gov registry record · Early Phase 1
Ketogenic Diet for Traumatic Brain Injury
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT03982602 is a Early Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 15 participants.
The verdict
NCT03982602, a Early Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
Traumatic Brain Injury is a major health concern in United States. There is a un-met need to develop new therapeutic options for faster neuron recovery without causing significant side effects. The role of ketones in neuronal recovery has been studied and has been found to be useful in decreasing size of contusion. The present study aims to study the safety and feasibility profile of ketogenic diet.
Interventions
- OTHER Ketogenic diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-07-04 |
| Est. Completion | 2024-04-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03982602
The ClinicalTrials.gov registry entry for NCT03982602 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketogenic diet is the first listed.
NCT03982602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03982602 about?
NCT03982602 is a clinical study titled "Ketogenic Diet for Traumatic Brain Injury". Traumatic Brain Injury is a major health concern in United States. There is a un-met need to develop new therapeutic options for faster neuron recovery without causing significant side effects. The role of ketones in neuronal recovery has been studied and has been found to be useful in decreasing si...
What is the current status of trial NCT03982602?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2019-07-04. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03982602?
The interventions under investigation include: Ketogenic diet (OTHER).
Who is sponsoring clinical trial NCT03982602?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.